Which ETFs hold BridgeBio Oncology Therapeutics, Inc.?
BBOT is held by 5 of the 504 ETFs we cover. The heaviest allocation is XBI at 0.1%; among the largest funds, SCHB holds 0.0% and VXF 0.0%. The median weight across all funds holding it is 0.0%.
- Covered ETFs Holding It
- 5
- Heaviest Allocation
- 0.07%in XBI
- Median Weight
- 0.01%across funds that hold it
Funds Holding BBOT(5)
| ETF | |||||||
|---|---|---|---|---|---|---|---|
| XBIState Street® SPDR® S&P® Biotech ETF | 0.07% | 0.35% | $10.0B | 0.36% | +29.2% | +85.3% | +4.5% |
| IBBiShares Biotechnology ETF | 0.04% | 0.44% | $9.3B | 0.21% | +17.3% | +51.0% | +3.1% |
| SCHASchwab U.S. Small-Cap ETF | 0.01% | 0.04% | $23.3B | 1.02% | +22.8% | +36.7% | +7.9% |
| VXFVanguard Extended Market Index Fund | 0.01% | 0.05% | $32.2B | 0.99% | +18.9% | +26.9% | +6.9% |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | 0.03% | $44.7B | 1.00% | +14.6% | +24.0% | +12.4% |
Expense = net expense ratio from the fund's latest SEC prospectus filing. YTD/1Y/5Y are trailing total returns including dividends (5Y annualized, as of 2026-08-07). Past performance does not predict future results. Sort by any column.
Frequently Asked Questions
Which ETF has the most BBOT exposure?
XBI has the heaviest BBOT allocation of the ETFs we cover, at 0.07% of its portfolio, based on the fund's latest SEC-reported holdings.
How many ETFs hold BBOT?
5 of the 504 ETFs we cover hold BridgeBio Oncology Therapeutics, Inc. (BBOT). The median weight across those funds is 0.01%.
What is the cheapest ETF that holds BBOT?
SCHB has the lowest expense ratio among covered ETFs holding BBOT, at 0.03% per year.
What is the largest ETF that holds BBOT?
SCHB (Schwab U.S. Broad Market ETF) is the largest covered ETF holding BBOT, with $44.7B in assets and a 0.00% position.
Keep Exploring
Look up another stock or compare two of these ETFs to see how much they overlap beyond BBOT.